Clear answers. Honest framing.

Juvion™ is a Swiss-developed nutrition platform focused on neuromuscular longevity — supporting how nerves and muscles communicate to maintain movement, strength and independence as we age.

Juvion-001™ is our first daily food supplement, designed to support motor neuron signalling, coordination, balance, muscle responsiveness and energy. It combines NADH, creatine, L-arginine, grape seed extract, vitamin D3 and piperine.

Movement starts in the nervous system. Over time nerve signals weaken, muscle response slows and coordination declines. Juvion targets the nerve-to-muscle interface — not just muscle mass.

Through three mechanisms: cellular energy (NADH, creatine), perfusion and nutrient delivery (L-arginine), and cellular protection (grape seed antioxidants, vitamin D3). Piperine enhances absorption.

Focus on neuromuscular signalling (not just muscle mass), synergistic formulation rather than single-ingredient marketing, Swiss-made precision and compliance, and a discovery process that combines AI-driven insight with clinical reasoning.

Juvion-001™ launches on 1 August 2026 (Swiss National Day) for waitlist members and online ordering at juvionswiss.com. Founders are prioritised in launch order.

Most users see meaningful effects after 8–12 weeks of daily use. Energy and reduced fatigue (8–12 weeks) → coordination and stamina (12–24 weeks) → strength reliability and mobility (24–52 weeks). Results vary by age, baseline health, activity, diet and lifestyle.

Compounds like creatine, NADH and vitamin D typically show measurable physiological changes within 12–24 weeks, with functional improvements often by 24–52 weeks. Juvion follows this evidence base.

Yes. 40–50: faster response on relatively preserved systems. 50–70: moderate response — consistency matters most. 70+: gradual improvements; benefits are more about stability and maintenance than rapid change.

Yes. Juvion-001™ is formulated as a food supplement using ingredients widely studied and considered safe at recommended doses. Manufactured in Switzerland under GMP, HACCP and ISO standards.

Most users tolerate it well. Mild and infrequent effects may include digestive discomfort or, occasionally, headache (with NADH in sensitive individuals). If symptoms persist, discontinue and consult a healthcare professional.

Juvion-001™ can usually be taken alongside medications, but you should consult a doctor if you are on long-term or multiple medications, recovering post-surgery, or living with diabetes, blood-pressure-sensitive conditions, anticoagulant therapy or kidney disease.

Individuals with chronic kidney disease, those on multiple cardiovascular medications, people with complex metabolic disorders, and pregnant or breastfeeding women should consult a doctor before use.

No. Juvion-001™ is a food supplement, not a pharmaceutical drug. It is designed to support normal body function and healthy aging. It does not diagnose, treat, cure or prevent disease.

One sachet daily, mixed in 200ml of still water. Best taken consistently for 52 weeks for full long-term benefit. Time of day is flexible — consistency matters more than timing.

Yes — and meaningfully. Best outcomes come from combining Juvion with light strength training, walking or balance exercises, good sleep and balanced nutrition.

Yes. Juvion-001 is designed for ongoing daily support — preventive nutrition, like supporting heart or brain health, rather than short-term supplementation.

Yes. The format, dosage and safety profile are designed with aging physiology in mind. Many subscribers buy on behalf of parents and report better adherence due to the simple daily routine.

It may support factors associated with fall risk, including coordination, muscle responsiveness and balance. It is not a fall-prevention treatment and should be combined with appropriate physiotherapy and balance training.

A food supplement (nutraceutical) formulated in Switzerland. It is not a medicinal product and does not make therapeutic claims. Best positioned as adjunctive support, not treatment.

Motor neuron signalling efficiency, neuromuscular junction function, and cellular energy metabolism — supported through mitochondrial energy (NADH, creatine), nitric-oxide-mediated perfusion (L-arginine), oxidative stress modulation (grape seed extract) and neuromuscular signalling (Vitamin D3).

Primary: age-related sarcopenia (early to moderate), reduced coordination or balance, fatigue impacting mobility, sedentary or frail elderly. Preventive: adults 50+ with declining performance, post-rehabilitation maintenance, early non-pathological neuromuscular decline.

Neurodegenerative diseases (e.g. ALS), advanced sarcopenia requiring medical management, or acute rehabilitation settings. In these cases, adjunct only — if at all.

Antihypertensives (L-arginine may potentiate hypotensive effects), anticoagulants/antiplatelets (grape seed extract may enhance bleeding risk), antidiabetics (L-arginine may influence insulin sensitivity). Statins are generally compatible.

As supportive nutrition for maintaining movement function, integrated alongside resistance training, balance work, adequate protein intake and Vitamin D optimisation. Not a replacement for medication, physical therapy or disease management.